Regulatory news​

Oslo, 9 July Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 3 July 2025, regarding the resolution by the extraordinary the general meeting to increase the Company's share capital in connection with a private placement (the "Private Placement") by the issuance of (i) 56,890,000…

Oslo, 4 July Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 1 July 2025, regarding the board of directors' resolution to increase the share capital of the Company by the issuance of 6,000,000 new shares to Jiangsu Hongxin Medical Technology Co. Ltd ("Jiangsu")…

Oslo, 3 July 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 11 June 2025 regarding the successfully placed private placement (the "Private Placement") of 72,890,000 new shares in the Company (the "Offer Shares") at a subscription price of NOK 0.50 per…

Oslo, 3 July 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR)) on 12 June 2025, regarding notice of an extraordinary general meeting in connection with, inter alia, a private placement (including a loan conversion to be completed by Navamedic ASA) and a…

Oslo, 1 July 2025 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker "OBSVR") is pleased to announce the strengthening of its strategic partnership with its key manufacturing partner, Jiangsu Hongxin Medical Technology Co. Ltd ("Jiangsu"), through Jiangsu's subscription for 6,000,000 shares in the Company. This agreement not only solidifies our collaboration but also…

Oslo, 1 July 2025 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker "OBSVR") is pleased to announce the strengthening of its strategic partnership with its key manufacturing partner, Jiangsu Hongxin Medical Technology Co. Ltd ("Jiangsu"), through Jiangsu’s subscription for 6,000,000 shares in the Company. This agreement not only solidifies our collaboration but also…

Oslo, 1 July 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 27 June 2025, regarding, inter alia, the resolution of the annual general meeting to reduce the Company's share capital by way of reducing the nominal value of each share with…

Oslo, 27 June 2025 The annual general meeting of Observe Medical ASA (the "Company" or "Observe Medical", Euronext Expand ticker "OBSRV") was held today, on 27 June 2025 at 10:00 hours (CEST), at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway. All resolutions were made in accordance with the proposals from the board of…

Oslo, 12 June 2025 Reference is made to the announcement made by Observe Medical ASA (the "Company" or "Observe Medical", and, together with its subsidiaries, the "Group", OSE ticker "OBSRV") on 11 June 2025, regarding the successfully placed private placement of new shares in the Company to raise gross proceeds totalling NOK 36,445,000 (the "Private…

Issuer name: Observe Medical ASA Ex. date: 12 June 2025 Type of corporate action: Subsequent offering/repair issue Other information: Reference is made to the stock exchange announcement published by Observe Medical ASA on 11 June 2025 with key information relating to the subsequent offering.   This information is published in accordance with the requirements of…

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED…

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, JAPAN, HONG KONG, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, PUBLICATION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN Oslo, 11 June…

Oslo, 6 June 2025 – Observe Medical ASA (OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, 27 June 2025, at 10:00 (CEST). The annual general meeting will be held at Dronning Eufemias gate 16, 2nd floor, 0191 Oslo, Norway. The notice of the annual general meeting is attached, together with the…

Oslo, May 30, 2025 – Observe Medical ("the Company" or "Observe Medical") has today published its Annual Report for 2024.  Observe Medical has today released its Annual Report 2024, including the Board of Directors report and financial statements. The report and annual accounts were approved by the Board of Directors on May 29, 2025. On 18…

Oslo, May 14, 2025 – Observe Medical ASA («Observe Medical» or the «Company») refers to the stock exchange announcement dated 25 October 2024, regarding the preliminary letter from the Norwegian Financial Supervisory Authority («NFSA» or «Finanstilsynet») on the review of the Company’s financial reporting. Reference is also made to section 4.3.2 of the prospectus published by…

Oslo, May 7, 2025 – Observe Medical ("the Company" or "Observe Medical") announces that the scheduled annual general meeting is postponed due to the delayed publication of the 2024 annual accounts. A new date for the annual general meeting will be announced as soon as the annual accounts are published. The Company is working with the…

Oslo, April 28, 2025 – Observe Medical ("the Company" or "Observe Medical") announces that the publication of its annual report for 2024 is delayed and is expected to be published no later than 30 May 2025. The audit is still ongoing and will not be completed by the 30 April deadline, resulting in a delay in…

Oslo, April 10[th], 2025 – Observe Medical ("the Company" or "Observe Medical") have reached agreements in principle with Convatec and Navamedic to reduce their debt position from in total NOK 82 million to NOK 41 million, with an adjusted payment plan for the remaining debt. Such debt reduction is conditional upon injection of new equity in…

Oslo, March 18, 2025 – Observe Medical ("the Company" or "Observe Medical") today releases its results and interim report for the second half and full year of 2024. Business update 2024 marked a pivotal transition toward the launch of UnoMeter Safeti Plus, historically the most revenue- and profit-generating product in the Convatec portfolio. Observe Medical is…

Oslo, 4 February 2025: Board member Kathrine Elisabeth Gamborg Andreassen has informed the board of directors of Observe Medical ASA (the "Company" or "Observe Medical") that she will resign from the Company's board of directors, effective 5 February 2025, in order to focus on her responsibilities as CEO of Navamedic ASA. Following the resignation, the…

Issuer name: Observe Medical ASA Ex. date: 14 January 2025 Type of corporate action: Reverse share split Other information: Fifteen (15) old shares will give one (1) new share. After the reverse share split, the share capital is NOK 75,107,806.80 divided into 19,258,412 shares, each with a nominal value of NOK 3.90. The shares in…

Date on which the corporate action was made public: 17 December 2024. Reverse split ratio: 15 old shares give 1 new share. Last day including right: 13 January 2025. Ex-date: 14 January 2025. Record date: 15 January 2025. Date of approval: 7 January 2025. Other information (optional): A new ISIN number will be issued for…

Issuer: Observe Medical ASA Previous ISIN: NO0010865009 New ISIN: NO0013457952 Date of ISIN change: 14 January 2025 This information is published in accordance with the requirements of the Continuing Obligations for companies listed on the Oslo Stock Exchange and Euronext Expand. For further information, please contact: Jørgen Mann, CEO Observe Medical Mobile: +45 408 67…

Date on which the corporate action was made public: 17 December 2024. Reverse split ratio: 15 old shares give 1 new share. Last day including right: 11 January 2025. Ex-date: 14 January 2025. Record date: 15 January 2025. Date of approval: 7 January 2025. Other information (optional): A new ISIN number will be issued for…

Oslo, 9 January 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 7 January 2025, regarding, inter alia, the resolution of the general meeting to increase the Company's share capital by NOK 1.30, through the issue of 5 new shares, each with…

Oslo, 7 January 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 7 January 2025 regarding the approval by the extraordinary general meeting of a share capital increase of NOK 1.30 through the issue of 5 new shares, each with a nominal…

Oslo, 7 January 2025 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 17 December 2024 regarding notice of an extraordinary general meeting. The extraordinary general meeting was held today, on 7 January 2025 at 10:00 (CET) at the Company's offices in Haakon VIIs…

Oslo, 17 December 2024 Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 5 December 2024 regarding the final results of the subsequent offering in the Company and the waiver of the condition for completion of the share capital increase of NOK 10,630,629.88, through the…

Date on which the corporate action was made public: 17 December 2024. Reverse split ratio: 15 old shares give 1 new share. Last day including right: To be decided by the board of directors (subject to approval by the extraordinary general meeting). Ex-date: To be decided by the board of directors (subject to approval by…

Oslo, 17 December 2024 An extraordinary general meeting of Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) will be held on 7 January 2025 at 10:00 (CET). The notice of the extraordinary general meeting, including agenda, proposed resolutions, registration form, a form of proxy and other relevant documents, is enclosed hereto. The…

Oslo, 13 December 2024: Observe Medical ASA (the "Company") has been informed that Seed Capital AS, a company owned 50% by Eskild Endrerud board member and primary insider in the Company, has purchased 178,268  shares in the Company as further specified in the attached notification form. Following the purchase, Seed Capital AS holds 242,335 shares…

Oslo, 13 December 2024 Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ticker "OBSVR") on 5 December 2024 regarding the final result of the subsequent offering in the Company, where a total of 2,303,933 new shares were subscribed and allocated at a subscription price of NOK 0.40…

Oslo, 12 December 2024: Observe Medical ASA (the "Company") has been informed that Rune Nystad, CDO and primary insider in the Company, has sold 1,144,962 shares in the Company to his wholly owned investment company US Holding AS as part of a reorganization of his shareholding.  Following this, 1,662,483 of the shares in Observe Medical ASA is…

Oslo, 12 December 2024 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) has today granted 500,000 share options to primary insider and CFO of the Company, Johan Fagerli. Each share option gives the right to purchase one share in the Company. The share options will vest over a period of two years.…

Oslo, 5 December 2024: Reference is made to the stock announcement published by Observe Medical ASA (the "Observe Medical") on 5 December 2024 regarding the final result of the subsequent offering and the partial conversion to shares of certain loans from Navamedic ASA ("Navamedic") to Observe Medical. Navamedic currently holds 4,222,727 shares in Observe Medical,…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 5 December 2024…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 4 December 2024…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 4 December 2024…

Oslo, 26 November 2024: Observe Medical ASA (the "Company") has been informed that Jørgen Mann, CEO and primary insider in the Company, has today purchased 100,000 shares in the Company as further specified in the attached notification form. Following the purchase, Jørgen Mann holds 600,000 shares in the Company. This information is subject to the…

Oslo, 26 November 2024: Observe Medical ASA (the "Company") has been informed that Terje Bakken, chairman of the board and primary insider in the Company, has today purchased 100,000 shares in the Company as further specified in the attached notification form. Following the purchase Terje Bakken holds 100,000 shares in the Company. In addition, Terje…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 19 November 2024…

Oslo, 19 November, 2024 – Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company" or "Observe Medical") on 12 November 2024, in which it inter alia was stated that the Company is in dialogue with strategic and financial partners to evaluate options to further strengthen its working capital situation. The…

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, 18 November 2024…

Oslo, 15 November 2024: Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 12 November 2024, in which it inter alia was stated that the Company is in dialogue with strategic and financial partners to evaluate options to further strengthen its working capital situation. The Company has (as…

Oslo, 26 August 2024 Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) has today granted 1,000,000 share options to primary insider and CEO of the Company, Jørgen Mann. Each share option gives the right to purchase one share in the Company. The share options will vest over a period of two years.…

Oslo, August 26, 2024 – Observe Medical ("the Company" or "Observe Medical") today releases its results for the first half of 2024. Business update In the first half of 2024, Observe Medical achieved growth and market expansion of the UnoMeter™ portfolio. Observe Medical has achieved a major milestone with the early commercial launch of the UnoMeter™…

Oslo, August 13, 2024 – Observe Medical ASA (the "Company" or "Observe Medical") announces the appointment of Jørgen Mann as its permanent Chief Executive Officer (“CEO”). Having served as interim CEO since February 2024, Mr. Mann has proven his leadership capabilities and deep insight into the Company's strategic operations. The board is fully confident in his…

Oslo, 6 August 2024 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 17 July 2024 (the "Announcement"), regarding share lending by Ingerø Reiten Investment Company AS in connection with tranche 2 of the private placement of new shares in the Company (the…

Oslo, 5 August 2024 Reference is made to the stock exchange announcement by Observe Medical ASA ("Observe Medical" or the "Company", OSE ticker: OBSVR) on 24 June 2024, regarding the successfully placed private placement of 55,000,000 new shares in the Company (the "Offer Shares") at a subscription price of NOK 0.40 per Offer Share to raise…